Literature DB >> 3501695

The metabolic pathology of the AIDS dementia complex.

D A Rottenberg1, J R Moeller, S C Strother, J J Sidtis, B A Navia, V Dhawan, J Z Ginos, R W Price.   

Abstract

A progressive dementing illness, the AIDS dementia complex (ADC) is the most frequent neurological complication of the acquired immunodeficiency syndrome. Characteristic alterations in regional cerebral metabolic rate for glucose (rCMRGlc), associated with the presence or progression of ADC, were demonstrated by [18F]fluorodeoxyglucose/positron emission tomography in 9 of 12 patients with ADC compared with 18 normal volunteer subjects. In these 9 patients, two distinct patterns of regional metabolic activity were highly correlated with intersubject gray matter rCMRGlc variation and with disease severity as assessed by neuropsychological testing. Relative subcortical (thalamus and basal ganglia) hypermetabolism was characteristic of early ADC, and disease progression was accompanied by cortical and subcortical gray matter hypometabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501695     DOI: 10.1002/ana.410220605

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  36 in total

1.  Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy.

Authors:  D López-Villegas; R E Lenkinski; I Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder.

Authors:  Thomas Ernst; Caroline S Jiang; Helenna Nakama; Steven Buchthal; Linda Chang
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

3.  Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy.

Authors:  T Baldeweg; J Catalan; B G Gazzard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

Review 4.  Nuclear medicine and AIDS.

Authors:  R F Miller
Journal:  Eur J Nucl Med       Date:  1990

Review 5.  Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND).

Authors:  Sanhita Sinharay; Dima A Hammoud
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

6.  Progressive brain atrophy in chronically infected and treated HIV+ individuals.

Authors:  Talia M Nir; Neda Jahanshad; Christopher R K Ching; Ronald A Cohen; Jaroslaw Harezlak; Giovanni Schifitto; Hei Y Lam; Xue Hua; Jianhui Zhong; Tong Zhu; Michael J Taylor; Thomas B Campbell; Eric S Daar; Elyse J Singer; Jeffry R Alger; Paul M Thompson; Bradford A Navia
Journal:  J Neurovirol       Date:  2019-02-14       Impact factor: 2.643

7.  A perspective on the proposal for neurocognitive disorder criteria in DSM-5 as applied to HIV-associated neurocognitive disorders.

Authors:  Karl Goodkin; Francisco Fernandez; Marshall Forstein; Eric N Miller; James T Becker; Antoine Douaihy; Luis Cubano; Flavia H Santos; Nelson Silva Filho; Jorge Zirulnik; Dinesh Singh
Journal:  Neuropsychiatry (London)       Date:  2011-10-01

Review 8.  Mental health aspects of HIV infection.

Authors:  J Hunter
Journal:  Can Fam Physician       Date:  1993-06       Impact factor: 3.275

Review 9.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.